Other pre-transplantation risk factors include serum biomarkers, such as alpha-fetoprotein (AFP) levels and the neutrophil to lymphocyte ratio (NLR), obesity, bridging therapy or time to transplantation [7,8,9]. This evidence concerns the gene AFP and obesity due to melanocortin 4 receptor deficiency.